Provenienza dei contatti di primo grado di Naozumi Harada
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
United Immunity Co. Ltd.
 United Immunity Co. Ltd. Pharmaceuticals: MajorHealth Technology United Immunity Co. Ltd. is a Japanese company that specializes in pipeline nano technology and immunity fusion technology, specifically in the field of cancer immunotherapy. The company is based in Tsu, Japan and was founded in 2017 by Naozumi Harada, who has been the CEO since then. The company's diverse products, including "nano immunotherapy," have shown promising clinical results and research in the treatment of sex cancer. The company is currently recruiting a researcher in the cancer immunotherapy field to analyze the action mechanism of nanotechnology applied cancer evaluation and drug evaluation using immunological methods. The company's focus is on the development of treatment for the cause of cold tumor type cancer through the understanding of tumor-associated macrophages.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Naozumi Harada tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
| Tokyo Institute of Technology | College/University | Doctorate Degree | |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Director/Board Member | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Pykus Therapeutics, Inc.
 Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Saisei Ventures LLC
 Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Giappone | 3 |
Settori
| Health Technology | 5 |
| Finance | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 8 |
| Corporate Officer/Principal | 3 |
| Private Equity Investor | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Hikaru Saito | 10 |
| Akihiko Watanabe | 1 |
| Yoshihito Daimon | 1 |
- Borsa valori
- Insiders
- Naozumi Harada
- Connessioni Società
